West Pharmaceutical Services (WST) Stock Forecast & Price Target

$304.74 +0.64 (+0.21%)

(As of 11:15 AM ET)

West Pharmaceutical Services - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 3 Analyst Ratings

Sell
0

Hold
1

Buy
2

Based on 3 Wall Street analysts who have issued ratings for West Pharmaceutical Services in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for WST.

Consensus Price Target

$460.33
51.06% Upside

According to the 3 analysts' twelve-month price targets for West Pharmaceutical Services, the average price target is $460.33. The highest price target for WST is $536.00, while the lowest price target for WST is $375.00. The average price target represents a forecasted upside of 51.06% from the current price of $304.74.

Get the Latest News and Ratings for WST and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for West Pharmaceutical Services and its competitors.

WST Analyst Ratings Over Time

Type	Current Forecast 11/21/23 to 11/20/24	1 Month Ago 10/22/23 to 10/21/24	3 Months Ago 8/23/23 to 8/22/24	1 Year Ago 11/21/22 to 11/21/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)	3 Buy rating(s)
Hold	1 Hold rating(s)	1 Hold rating(s)	1 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$460.33	$442.75	$442.75	$355.00
Forecasted Upside	51.06% Upside	54.13% Upside	47.33% Upside	0.58% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Buffett Dumps $982 Million in BofA Stock—What Does He Know? (Ad)

Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.

Get your FREE, no-obligation Wealth Protection Guide now

WST Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

WST Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

West Pharmaceutical Services Stock vs. The Competition

Type	West Pharmaceutical Services	Medical Companies	S&P 500
Consensus Rating Score	2.67	2.80	2.50
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	51.39% Upside	27,980.85% Upside	9.99% Upside
News Sentiment Rating	Positive News See Recent WST News	Neutral News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
2/16/2024	UBS Group 4 of 5 stars	Lower Target	Neutral ➝ Neutral	$400.00 ➝ $375.00	+3.29%
2/13/2024	KeyCorp 3 of 5 stars	Boost Target	Overweight ➝ Overweight	$440.00 ➝ $470.00	+15.58%
2/7/2024	Jefferies Financial Group 2 of 5 stars	Upgrade	Hold ➝ Buy	$323.00 ➝ $536.00	+34.58%
10/27/2023	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Target	Overweight ➝ Overweight	$420.00 ➝ $390.00	+20.06%
6/16/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$390.00 ➝ $405.00	+12.56%
2/22/2023	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target		$250.00 ➝ $290.00	-5.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:34 AM ET.

Should I Buy West Pharmaceutical Services Stock? WST Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, November 8, 2024. Please send any questions or comments about these West Pharmaceutical Services pros and cons to contact@marketbeat.com.

West Pharmaceutical Services
Bull Case

Here are some ways that investors could benefit from investing in West Pharmaceutical Services, Inc.:

West Pharmaceutical Services, Inc. has a strong market capitalization of $22.00 billion, indicating stability and potential for growth.
The company's current stock price of $311.00 presents a potential buying opportunity for investors looking to enter at a favorable price point.
West Pharmaceutical Services, Inc. has a diverse product portfolio catering to the healthcare industry globally, providing a stable revenue stream.
The company's consistent focus on innovation and product development ensures it stays competitive in the market and drives future growth.
West Pharmaceutical Services, Inc. has a solid financial position with a low debt-to-equity ratio of 0.03, indicating prudent financial management.

West Pharmaceutical Services
Bear Case

Investors should be bearish about investing in West Pharmaceutical Services, Inc. for these reasons:

West Pharmaceutical Services, Inc. recently reported a decrease in quarterly revenue, which may raise concerns about its growth trajectory.
The company's PE ratio of 40.02 and P/E/G ratio of 10.94 suggest that the stock may be overvalued compared to its growth prospects.
West Pharmaceutical Services, Inc. has experienced a decline in stock price from its fifty-two week high of $413.70, indicating potential volatility in the market.
The beta of 1.01 for West Pharmaceutical Services, Inc. implies that the stock's price movements may be closely correlated with the overall market, potentially leading to higher risk.
Analysts' consensus estimates for West Pharmaceutical Services, Inc. suggest a lower EPS compared to previous periods, signaling potential challenges in earnings growth.

WST Forecast - Frequently Asked Questions

: According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for West Pharmaceutical Services is $460.33, with a high forecast of $536.00 and a low forecast of $375.00.
: 3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" WST shares.
: According to analysts, West Pharmaceutical Services's stock has a predicted upside of 51.06% based on their 12-month stock forecasts.
: Analysts like West Pharmaceutical Services less than other "medical" companies. The consensus rating score for West Pharmaceutical Services is 2.67 while the average consensus rating score for "medical" companies is 2.80. Learn more on how WST compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

I've got news for you… (Ad)

Today, I’m doing something I thought I’d never do… Especially since I’m not normally a “swing for the fences” type of trader. But I’ve been quietly testing a new type of trade for a while now… And the returns are too good not to share with you. Take a look… I can’t guarantee results or against losses, but if you want to discover how I’ll target the triple return before the end of the week

watch this FREE briefing with me and expert trader Graham Lindman

This page (NYSE:WST) was last updated on 11/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

West Pharmaceutical Services (WST) Stock Forecast & Price Target